131 related articles for article (PubMed ID: 21256112)
1. Apoptosis induces Bcl-XS and cleaved Bcl-XL in chronic lymphocytic leukaemia.
Willimott S; Merriam T; Wagner SD
Biochem Biophys Res Commun; 2011 Feb; 405(3):480-5. PubMed ID: 21256112
[TBL] [Abstract][Full Text] [Related]
2. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
Lindenboim L; Yuan J; Stein R
Oncogene; 2000 Mar; 19(14):1783-93. PubMed ID: 10777212
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.
Buske C; Gogowski G; Schreiber K; Rave-Fränk M; Hiddemann W; Wörmann B
Exp Hematol; 1997 Apr; 25(4):329-37. PubMed ID: 9131008
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis-modulating interaction of the neuregulin/erbB pathway with anthracyclines in regulating Bcl-xS and Bcl-xL in cardiomyocytes.
Rohrbach S; Muller-Werdan U; Werdan K; Koch S; Gellerich NF; Holtz J
J Mol Cell Cardiol; 2005 Mar; 38(3):485-93. PubMed ID: 15733908
[TBL] [Abstract][Full Text] [Related]
5. CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia.
Willimott S; Baou M; Naresh K; Wagner SD
Br J Haematol; 2007 Sep; 138(6):721-32. PubMed ID: 17760804
[TBL] [Abstract][Full Text] [Related]
6. A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells.
Zangemeister-Wittke U; Leech SH; Olie RA; Simões-Wüst AP; Gautschi O; Luedke GH; Natt F; Häner R; Martin P; Hall J; Nalin CM; Stahel RA
Clin Cancer Res; 2000 Jun; 6(6):2547-55. PubMed ID: 10873111
[TBL] [Abstract][Full Text] [Related]
7. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
[TBL] [Abstract][Full Text] [Related]
8. Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells.
Villedieu M; Louis MH; Dutoit S; Brotin E; Lincet H; Duigou F; Staedel C; Gauduchon P; Poulain L
Gynecol Oncol; 2007 Apr; 105(1):31-44. PubMed ID: 17275076
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
[TBL] [Abstract][Full Text] [Related]
10. [Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer].
Zhu HB; Huang XF; Hu JZ; Zhou W; Chen W; Chen LL; He C
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):245-9. PubMed ID: 18788624
[TBL] [Abstract][Full Text] [Related]
11. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
Dole MG; Jasty R; Cooper MJ; Thompson CB; Nuñez G; Castle VP
Cancer Res; 1995 Jun; 55(12):2576-82. PubMed ID: 7780971
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone inhibits spontaneous apoptosis in primary cultures of human and rat hepatocytes via Bcl-2 and Bcl-xL induction.
Bailly-Maitre B; de Sousa G; Boulukos K; Gugenheim J; Rahmani R
Cell Death Differ; 2001 Mar; 8(3):279-88. PubMed ID: 11319611
[TBL] [Abstract][Full Text] [Related]
13. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases.
Fujita N; Nagahashi A; Nagashima K; Rokudai S; Tsuruo T
Oncogene; 1998 Sep; 17(10):1295-304. PubMed ID: 9771973
[TBL] [Abstract][Full Text] [Related]
14. Bcl-xS enhances adenoviral vector-induced apoptosis in neuroblastoma cells.
Dole MG; Clarke MF; Holman P; Benedict M; Lu J; Jasty R; Eipers P; Thompson CB; Rode C; Bloch C; Nuñez ; Castle VP
Cancer Res; 1996 Dec; 56(24):5734-40. PubMed ID: 8971184
[TBL] [Abstract][Full Text] [Related]
15. Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone.
Lotem J; Sachs L
Cell Growth Differ; 1995 Jun; 6(6):647-53. PubMed ID: 7669718
[TBL] [Abstract][Full Text] [Related]
16. Expression of Bcl-XS alters cytokinetics and decreases clonogenic survival in K12 rat colon carcinoma cells.
Fridman JS; Rehemtulla A; Hofmann A; Blau HM; Maybaum J
Oncogene; 1998 Dec; 17(23):2981-91. PubMed ID: 9881700
[TBL] [Abstract][Full Text] [Related]
17. Diallyl trisulphide-induced apoptosis in human melanoma cells involves downregulation of Bcl-2 and Bcl-xL expression and activation of caspases.
Zhou C; Mao XP; Guo Q; Zeng FQ
Clin Exp Dermatol; 2009 Dec; 34(8):e537-43. PubMed ID: 20055834
[TBL] [Abstract][Full Text] [Related]
18. Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL.
Emanuele S; D'Anneo A; Bellavia G; Vassallo B; Lauricella M; De Blasio A; Vento R; Tesoriere G
Eur J Cancer; 2004 Jun; 40(9):1441-52. PubMed ID: 15177505
[TBL] [Abstract][Full Text] [Related]
19. Developmental consequences of alternative Bcl-x splicing during preimplantation embryo development.
Perumalsamy A; Fernandes R; Lai I; Detmar J; Varmuza S; Casper RF; Jurisicova A
FEBS J; 2010 Mar; 277(5):1219-33. PubMed ID: 20136652
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by dexamethasone of transforming growth factor beta1-induced apoptosis in rat hepatoma cells: a possible association with Bcl-xL induction.
Yamamoto M; Fukuda K; Miura N; Suzuki R; Kido T; Komatsu Y
Hepatology; 1998 Apr; 27(4):959-66. PubMed ID: 9537434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]